G-protein-coupled receptor kinase activity is increased in hypertension

Journal of Clinical Investigation

Volumn 99, Issue 9, 1997, Pages 2087-2093

  Gros, Robert ^a   Benovic, Jeffrey L ^b   Tan, Christopher M ^a   Feldman, Ross D ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

adenylyl cyclase; adrenoceptors; aging; cyclic AMP dependent protein kinase

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RHODOPSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE LOCUS; HUMAN; HUMAN CELL; HYPERTENSION; LYMPHOCYTE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 0031000256     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119381     Document Type: Article

References (34)

1. Feldman, R.D. 1990. Defective venous β-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J. Clin. Invest. 85: 647-652.
2. Naslund, T., D.J. Silberstein, W.J. Merrell, J.H. Nadeau, and A.J.J. Wood. 1990. Low sodium intake corrects abnormality in β-receptor-mediated arterial vasodilation in patients with hypertension: correlation with β-receptor function in vitro. Clin. Pharmacol. Ther. 48:87-95.
3. Feldman, R.D. 1987. Beta-adrenergic receptor alterations in hypertension: physiological and molecular correlates. Can. J. Physiol. Pharmacol. 65: 1666-1672.
4. Feldman, R.D., C.M. Tan, and J. Chorazyczewski. 1995. G-Protein alterations in hypertension and aging. Hypertension (Dallas). 26:725-732.
5. Feldman, R.D. 1992. A low sodium diet corrects the defect in β-adrenergic response in older subjects. Circulation. 85:612-618.
6. Mills, P.J., M.G. Ziegler, R.A. Nelesen, and B.P. Kennedy. 1996. The effects of the menstrual cycle, race, and gender on adrenergic receptors and agonists. Clin. Pharmacol. Ther. 60:99-104.
7. Venter, C.P., S. Daya, P.H. Joubert, and W.J. Strydom. 1985. Ethnic differences in human lymphocytic cyclic AMP production after isoprenaline stimulation and propranolol blockade. Br. J. Clin. Pharmacol. 19:187-190.
8. Feldman, R.D., W.J. Lawton, and W.L. McArdle. 1987. Low sodium diet corrects the defect in lymphocyte β-adrenergic responsiveness in hypertensive subjects. J. Clin. Invest. 79:290-294.
9. Feldman, R., L.E. Limbird, J. Nadeau, D. Robertson, and A.J.J. Wood. 1984. Leukocyte beta receptor alterations in hypertensive subjects. J. Clin. Invest. 73:648-653.
10. Hausdorff, W.P., M.G. Caron, and R.J. Lefkowitz. 1990. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB (Fed. Am. Soc. Exp. Biol.) J. 4:2881-2889.
11. Lefkowitz, R.J., W.P. Hausdorff, and M.G. Caron. 1990. Role of phos-phorylation in desensitization of the β-adrenoceptor. TIPS (Trends Pharmacol. Sci.). 11:190-194.
12. Barnes, P.J. 1995. State of the art. Beta-adrenergic receptors and their regulation. Am. J. Resp. Crit. Care Med. 152:838-860.
13. Koch, W.J., H.A. Rockman, P. Sarmama, R. Hamilton, R.A. Bond, C.A. Milano, and R.J. Lefkowitz. 1995. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science (Wash. DC). 268:1350-1353.
14. 2-adrenergic receptors. J. Biol. Chem. 268:3201-3208.
15. Ungerer, M., M. Bohm, J.S. Elce, E. Erdmann, and M.J. Lohse. 1993. Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart. Circulation. 87:454-463.
16. Ping, P., A. Li, C. Bentley, and H.K. Hammond. 1995. Increased G-protein receptor kinase activity and expression during development of heart failure. Circulation. 92:57a. (Abstr.)
17. Böyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scan. J. Clin. Lab. Invest. 21(Suppl. 97):77-89.
18. Feldman, R.D. 1993. Insulin-mediated sensitization of adenylylcyclase activation. Br. J. Pharmacol. 110:1640-1644.
19. Benovic, J.L., F. Mayor, Jr., C. Staniszewsi, R.J. Lefkowitz, and M.G. Caron. 1987. Purification and characterization of the β-adrenergic receptor kinase. J. Biol. Chem. 262:9026-9032.
20. Loudon, R.P., B. Perussia, and J.L. Benovic. 1996. Differentially regulated expression of the G protein-coupled receptor kinases, βARK and GRK6, during myelomonocytic cell development in vitro. Blood. 88:4547-4557.
21. Donosa, L.A., D.S. Gregerson, L. Smith, S. Robertson, V. Knospe, T. Vrabec, and C.M. Kalsow. 1990. S-antigen: preparation and characterization of site-specific monoclonal antibodies. Curr. Eye Res. 9:343-355.
22. Brodde, O.-E., A.E. Daul, N. O'Hara, and A.M. Khalifa. 1985. Properties of α- and β-adrenoceptors in circulating blood cells of patients with essential hypertension. J. Cardiovasc. Pharmacol. 7:S162-S167.
23. Silver, P.J., R.J. Michalak, and S.M. Kocmund. 1985. Role of cyclic AMP protein kinase in decreased arterial cyclic AMP responsiveness in hypertension. J. Pharmacol. Exp. Ther. 232:595-601.
24. 2-adrenergic receptor. J. Biol. Chem. 269:13084-13087.
25. De Blasi, A., G. Parruti, and M. Sallese. 1995. Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. J. Clin. Invest. 95: 203-210.
26. Shasha, S.M., U. Shasha, B. Kristal, M. Barzilai, O. Steinberger, and T. Shkolnik. 1991. Proliferative response of T lymphocytes to mitogenic lectins in essential hypertension. Nephron. 58:413-417.
27. Paietta, E., and J.D. Schwarzmeier. 1983. Beta-adrenergic responsiveness of human peripheral lymphocytes after mitogenic transformation with phytohemagglutinin. Biochem. Pharmacol. 32:3085-3089.
28. Laxminarayana, D., and G.M. Kammer. 1996. Activation of type 1 protein kinase A during receptor-mediated human T lymphocyte activation. J. Immunol. 156:497-506.
29. Mills, P.J., C.C. Berry, J.E. Dimsdale, M.G. Ziegler, R.A. Nelesen, and B.P. Kennedy. 1995. Lymphocyte subset redistribution in response to acute experimental stress: effects of gender, ethnicity, hypertension, and the sympathetic nervous system. Brain Behav. Immun. 9:61-69.
30. Stiles, G.L. 1991. Adrenergic receptor responsiveness and congestive heart failure. Am. J. Cardiol. 67:13C-17C.
31. Kiuchi, K., R.P. Shannon, K. Komamura, D.J. Cohen, C. Bianchi, C.J. Homey, S.F. Vatner, and D.E. Vatner. 1993. Hyocardial β-adrcnergic receptor function during the development of pacing-induced heart failure. J. Clin. Invest. 91:907-914.
32. Colucci, W.S., J.P. Ribeiro, M.B. Rocco, R.J. Quigg, M.A. Creager, J.D. Marsh, D.F. Gauthier, and L.H. Hartley. 1989. Impaired chronotrophic response to exercise in patients with congestive heart failure. Role of postsynaptic β-adrenergic desensitization. Circulation. 80:314-323.
33. Maisel, A.S., C. Phillips, M.C. Michel, M.G. Ziegler, and S.M. Carter. 1989. Regulation of cardiac β-adrenergic receptors by captopril. Implications for congestive heart failure. Circulation. 80:669-675.
34. Goldstein, D.S. 1981. Plasma norepinephrine in essential hypertension. A study of the studies. Hypertension (Dallas.). 3:48-52.